Komori
Management planning2927AFC-HD AMS Life Science Co.,Ltd.Food

Notice Regarding the Formulation of a Medium-Term Management Plan

A new medium-term management plan has been formulated covering the 5 fiscal years from the fiscal year ending August 2027 through the fiscal year ending August 2031. It sets a consolidated revenue target of ¥45.44 billion for the final year and outlines growth initiatives for each business, including OEM, overseas operations, e-commerce, pharmaceuticals and real estate.

Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
45440
¥ millions (consolidated revenue target for the fiscal year ending August 2031)
Wording
Conditional
How definitive the wording is.

Items stated in the management plan

Formulated
Medium-Term Management Plan (2027-2031)Plan period Fiscal years ending August 2027 through August 2031 (5-year plan)
Publication date 16 October 2026
Net Sales+32.4%
基準 34,324Target45,440million

Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.

Key initiatives
01Strengthen the competitiveness of the OEM business
02Expanding the Overseas Business
03Strengthen the earnings base of the e-commerce business
04Strengthen the sales strategy based at the Tokyo Branch
05Strengthen the earnings power and supply structure of the pharmaceutical business
06Improve profitability through the department store business and the utilization of real estate
07Strengthen the growth base of the food service business
08Strengthen the comprehensive capabilities of the real estate and construction leasing business
09Expand the business base for tourism, institutional catering and education, among other areas
Plan assumptionsGrowing health consciousness, Advancing population aging, Growing demand in overseas markets for Japanese products offering high quality and safety
Segment targetSegment OEM Business / Sales Target ¥15 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Overseas Operations / Sales Target ¥6 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Mail-Order Business / Sales Target ¥4.029 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Tokyo Office / Sales Target ¥2.23 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Pharmaceuticals Business / Sales Target ¥3.7 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Department Store Business / Sales Target ¥5.1 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Foodservice Business / Sales Target ¥2.611 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Real Estate and Construction Contracting Business / Sales Target ¥3.65 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Other Businesses / Sales Target ¥2.984 billion (fiscal year ending August 2031) / Profit Target Not disclosed
Non-financial targetsIndicator Total number of customers / Target value 660,000 (currently 220,000) / Timing Five years from now, Indicator Number of subscription customers / Target value 160,000 (currently 39,000) / Timing Five years from now, Indicator Percentage of proposals combining lifestyle improvement medicines and Kampo formulations / Target value 50% / Timing Not disclosed, Indicator Stockout rate / Target value Maintain at 1% or below / Timing Not disclosed, Indicator Percentage of online consultations in the self-pay medical care segment / Target value Increase to 50% / Timing Not disclosed, Indicator Retention rate of existing business partners / Target value Maintain at 95% or above / Timing Not disclosed, Indicator Number of customers in the tourism business / Target value 3x / Timing Within 3 years, Indicator Number of new customers in the tourism business / Target value At least 3,000 annually / Timing Each year, Indicator Repeat rate in the tourism business / Target value 60% or more / Timing Not disclosed, Indicator Utilization rate of ラビット急行 for organized tours / Target value Maintain at 80% or above / Timing Not disclosed, Indicator Number of tour buses / Target value Add 5 buses / Timing January 2028
Items stated in the management plan
ItemDetails
Plan nameMedium-Term Management Plan (2027-2031)
Plan periodFiscal years ending August 2027 through August 2031 (5-year plan)
Progress against the planFormulated
Sales Target34,324 (fiscal year ending August 2026) → 45,440 (fiscal year ending August 2031)
Segment targetSegment OEM Business / Sales Target ¥15 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Overseas Operations / Sales Target ¥6 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Mail-Order Business / Sales Target ¥4.029 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Tokyo Office / Sales Target ¥2.23 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Pharmaceuticals Business / Sales Target ¥3.7 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Department Store Business / Sales Target ¥5.1 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Foodservice Business / Sales Target ¥2.611 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Real Estate and Construction Contracting Business / Sales Target ¥3.65 billion (fiscal year ending August 2031) / Profit Target Not disclosed, Segment Other Businesses / Sales Target ¥2.984 billion (fiscal year ending August 2031) / Profit Target Not disclosed
Non-financial targetsIndicator Total number of customers / Target value 660,000 (currently 220,000) / Timing Five years from now, Indicator Number of subscription customers / Target value 160,000 (currently 39,000) / Timing Five years from now, Indicator Percentage of proposals combining lifestyle improvement medicines and Kampo formulations / Target value 50% / Timing Not disclosed, Indicator Stockout rate / Target value Maintain at 1% or below / Timing Not disclosed, Indicator Percentage of online consultations in the self-pay medical care segment / Target value Increase to 50% / Timing Not disclosed, Indicator Retention rate of existing business partners / Target value Maintain at 95% or above / Timing Not disclosed, Indicator Number of customers in the tourism business / Target value 3x / Timing Within 3 years, Indicator Number of new customers in the tourism business / Target value At least 3,000 annually / Timing Each year, Indicator Repeat rate in the tourism business / Target value 60% or more / Timing Not disclosed, Indicator Utilization rate of ラビット急行 for organized tours / Target value Maintain at 80% or above / Timing Not disclosed, Indicator Number of tour buses / Target value Add 5 buses / Timing January 2028
Plan assumptionsGrowing health consciousness, Advancing population aging, Growing demand in overseas markets for Japanese products offering high quality and safety
Key initiativesStrengthen the competitiveness of the OEM business, Expanding the Overseas Business, Strengthen the earnings base of the e-commerce business, Strengthen the sales strategy based at the Tokyo Branch, Strengthen the earnings power and supply structure of the pharmaceutical business, Improve profitability through the department store business and the utilization of real estate, Strengthen the growth base of the food service business, Strengthen the comprehensive capabilities of the real estate and construction leasing business, Expand the business base for tourism, institutional catering and education, among other areas
Publication date16 October 2026
Items this document does not state (16)
Operating profit targetOperating profit margin targetNet income targetROE targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorResults under the previous planReason for revision or withdrawalSize of the Target MarketRisks identifiedDate of board resolution

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The plan is based on the business environment of growing health consciousness, advancing population aging, and increasing demand in overseas markets for Japanese products offering high quality and safety. Its aim is to strengthen the competitiveness and earnings power of each business and achieve sustainable growth for the Group as a whole and enhance corporate value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Formulation of a Medium-Term Management Plan | AFC-HD AMS Life Science Co.,Ltd. (2927) timely disclosure | Komori